Kidney Dialysis Market Report 2026

The kidney dialysis market size has grown strongly in recent years. It will grow from $90.88 billion in 2025 to $97.98 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rising prevalence of chronic kidney disease, increasing incidence of diabetes and hypertension, growing reliance on dialysis as renal replacement therapy, expansion of dialysis centers and hospitals, availability of government reimbursement programs.

The kidney dialysis market size is expected to see strong growth in the next few years. It will grow to $134.49 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing aging population with kidney disorders, increasing adoption of home dialysis solutions, rising healthcare expenditure on renal care, technological advancements in dialysis equipment, expanding access to dialysis services in developing regions. Major trends in the forecast period include rising adoption of home-based dialysis therapies, increasing preference for peritoneal dialysis modalities, growing demand for patient-centric dialysis services, expansion of dialysis infrastructure in emerging markets, improved safety and efficiency of dialysis equipment.

The increasing prevalence of chronic kidney diseases is anticipated to drive the growth of the kidney dialysis market in the coming years. Chronic kidney disease (CKD) is a long-term, progressive disorder in which the kidneys steadily lose their ability to function effectively. It is marked by a gradual decline in kidney function over several months or years. Kidney dialysis is mainly required for individuals with chronic kidney disease (CKD) when the kidneys can no longer sufficiently eliminate waste products and excess fluids from the body. For example, in June 2023, according to Kidney Research UK, a UK-based charitable organization focused on research and advocacy to enhance the understanding, prevention, and treatment of kidney diseases, approximately 7.19 million people in the UK were living with chronic kidney disease in 2023, accounting for over 10% of the UK population, with this number expected to rise to 7.61 million by 2033. As a result, the growing burden of chronic kidney disorders is fueling the expansion of the kidney dialysis market.

Major companies operating in the kidney dialysis market are focusing on developing kidney health technologies to improve patient outcomes, increase treatment efficiency, and enable remote monitoring and management of kidney conditions. Kidney health technologies include advanced tools and solutions designed to assess, monitor, and manage kidney function and related diseases. For example, in April 2023, Medtronic plc, a U.S.-based medical device company, introduced Mozarc Medical. Mozarc Medical focuses on creating patient-centered technologies that address the changing needs of people with kidney disease. The company seeks to develop solutions that improve the quality of life for patients receiving kidney failure treatments, with a strong emphasis on at-home dialysis options.

In April 2023, M42, a UAE-based technology-enabled healthcare company, acquired Diaverum AB for an undisclosed sum. With this acquisition, M42 will strengthen its platform to expand its healthcare operations, provide innovative patient-centric solutions globally, and access Diaverum’s extensive international network of clinics and patients. Diaverum AB is a Sweden-based healthcare provider specializing in kidney dialysis services, including hemodialysis, renal care, and treatments for kidney failure.

Major companies operating in the kidney dialysis market are Fresenius SE & Co. KGaA, Baxter International Inc., DaVita Inc., B. Braun Melsungen AG, Nipro Corporation, Asahi Kasei Corporation, Nikkiso Co. Ltd., Toray Medical Co. Ltd., JMS Co. Ltd., Kawasumi Laboratories Inc., Outset Medical Inc., Quanta Dialysis Technologies Ltd., Rockwell Medical Inc., CytoSorbents Corporation, Diaverum AB, Satellite Healthcare Inc., Allmed Medical Care Holdings Ltd., Dialife SA, SWS Hemodialysis Care Co. Ltd., Medtronic plc, NxStage Medical Inc.

North America was the largest region in the kidney dialysis market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney dialysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the kidney dialysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have moderately impacted the kidney dialysis market by increasing the cost of imported dialysis machines, consumables, and critical components such as filters and tubing. Product segments including hemodialysis equipment and peritoneal dialysis consumables are most affected, particularly in North America and Europe due to dependence on global manufacturing and supply chains. Dialysis centers and hospitals face higher procurement and operational costs, which may influence treatment pricing. However, tariffs have also encouraged local manufacturing, strengthened regional supply chains, and supported long-term cost optimization in dialysis equipment and consumable production.

The kidney dialysis market research report is one of a series of new reports that provides kidney dialysis market statistics, including kidney dialysis industry global market size, regional shares, competitors with a kidney dialysis market share, detailed kidney dialysis market segments, market trends and opportunities, and any further data you may need to thrive in the kidney dialysis industry. This kidney dialysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Kidney dialysis is a medical treatment process that artificially carries out the functions of the kidneys when they are no longer able to effectively filter waste materials or regulate fluid and electrolyte levels in the body. In this procedure, specialized equipment and methods are employed to eliminate waste substances, excess fluids, and toxins from the blood - functions that are typically performed by healthy kidneys.

The primary types of dialysis include hemodialysis and peritoneal dialysis. Hemodialysis is a process that uses a dialysis machine along with a specialized filter, commonly referred to as an artificial kidney or dialyzer, to clean and purify the blood. It encompasses products and services such as equipment, consumables, dialysis medications, and related services. The key end users include home care settings, dialysis centers, hospitals, and others.

The kidney dialysis market consists of revenues earned by entities by providing kidney dialysis services such as treatment planning and assessment, monitoring and adjustments, medication management, and coordination of care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The kidney dialysis market also includes sales of dialysis machines, dialyzers, dialysis catheters, vascular access devices, tubing and connectors, and dialysis solution bags, which are used in providing kidney dialysis services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.